Inventor · disambiguated record
Barton W. Phillips
Also filed as: PHILLIPS BARTON · PHILLIPS BARTON W
45 granted patents·10 pending applications·144 citations·filing 2002–2025
97Inventor score
Files withGILEAD SCIENCES INC31BAYER PHARMACEUTICALS CORP7BAYER HEALTHCARE LLC5DIXON JULIE A4GILEAD PHARMASSET LLC2
Top patents by PatentIndex Score
55 records- 0196US11584738B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 21, 2023·11 cites·47 claims
- 0294US11702407B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Jul 18, 2023·5 cites·26 claims
- 0394US11548871B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Jan 10, 2023·3 cites·30 claims
- 0493US10774071B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Sep 15, 2020·7 cites·18 claims
- 0592US9296782B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2013·Granted Mar 29, 2016·13 cites·16 claims
- 0691US10710986B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 14, 2020·4 cites·5 claims
- 0788US10040781B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Aug 7, 2018·3 cites·48 claims
- 0888US7563791B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Jul 21, 2009·14 cites·8 claims
- 0985US7557129B2Cyanopyridine derivatives useful in the treatment of cancer and other disordersBAYER HEALTHCARE LLC·Filed 2004·Granted Jul 7, 2009·18 cites·18 claims
- 1083US11555029B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jan 17, 2023·1 cites·9 claims
- 1182US9655944B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2016·Granted May 23, 2017·2 cites·2 claims
- 1281US10072001B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Sep 11, 2018·3 cites·30 claims
- 1380US10335409B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2018·Granted Jul 2, 2019·1 cites·2 claims
- 1480US7928227B22-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disordersBAYER HEALTHCARE LLC·Filed 2004·Granted Apr 19, 2011·10 cites·28 claims
- 1580US7585888B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2008·Granted Sep 8, 2009·4 cites·5 claims
- 1679US8143393B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2006·Granted Mar 27, 2012·5 cites·11 claims
- 1779US7384947B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2006·Granted Jun 10, 2008·2 cites·5 claims
- 1878US8129379B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2009·Granted Mar 6, 2012·4 cites·2 claims
- 1978US8076488B2Bicyclic urea derivatives useful in the treatment of cancer and other disordersDUMAS JACQUES·Filed 2004·Granted Dec 13, 2011·10 cites·32 claims
- 2078US2025270195A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2177US12338233B2PD-1/Pd-L1 inhibitorsGILEAD SCIENCES INC·Filed 2022·Granted Jun 24, 2025·0 cites·4 claims
- 2277US12139474B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Nov 12, 2024·0 cites·4 claims
- 2377US8431695B2Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseasesO'CONNOR STEPHEN·Filed 2006·Granted Apr 30, 2013·5 cites·6 claims
- 2476US10221197B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 5, 2019·2 cites·13 claims
- 2575US10092563B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Oct 9, 2018·2 cites·11 claims
- 2673US10603318B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2019·Granted Mar 31, 2020·0 cites·2 claims
- 2772US11999717B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jun 4, 2024·0 cites·23 claims
- 2872US8133995B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE·Filed 2006·Granted Mar 13, 2012·4 cites·13 claims
- 2972US7998950B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2009·Granted Aug 16, 2011·1 cites·17 claims
- 3072US2025304554A1Lpa receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 3171US8829185B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2012·Granted Sep 9, 2014·2 cites·5 claims
- 3270US7144885B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Dec 5, 2006·4 cites·26 claims
- 3369US7803956B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Granted Sep 28, 2010·0 cites·19 claims
- 3468US11939318B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 3567US10308639B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Jun 4, 2019·1 cites·20 claims
- 3667US7659412B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2008·Granted Feb 9, 2010·0 cites·8 claims
- 3767US7351735B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Apr 1, 2008·3 cites·21 claims
- 3862US8338595B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2009·Granted Dec 25, 2012·0 cites·8 claims
- 3961US2017290827A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 4060US12269812B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 8, 2025·0 cites·11 claims
- 4159US10253019B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2018·Granted Apr 9, 2019·0 cites·13 claims
- 4258US2016130300A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4354US7420066B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 2, 2008·0 cites·7 claims
- 4453US2013225809A1Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER HEALTHCARE LLC·Filed 2012·Application pending·0 cites
- 4552US10259811B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2018·Granted Apr 16, 2019·0 cites·10 claims
- 4648US2018305315A1Pd-1/pd-l1 inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 4747US10899735B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jan 26, 2021·0 cites·9 claims
- 4846US11236085B2PD-1/PD-L1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Feb 1, 2022·0 cites·28 claims
- 4946US8338594B2Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinaseMAGNUSON STEVEN·Filed 2006·Granted Dec 25, 2012·0 cites·14 claims
- 5042US2008293696A12-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic AgentsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Barton W. Phillips files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →